Genomic and expression analysis of a solute carrier protein (CcSLC25a5) gene from Cyprinus carpio Linnaeus
© Jiang et al.; licensee Springer. 2013
Received: 22 May 2013
Accepted: 4 September 2013
Published: 12 September 2013
Using the Genefishing method, we identified seven potential regulatory genes involved in the process of scale morphogenesis in fishes. We further characterized a novel solute carrier protein gene (CcSLC), from the common carp which is differentially expressed in mirror carp and Jianli. The ORF encodes a peptide of 298 amino acids with a molecular mass of 31.5 kDa and a theoretical isoelectric point of 7.49. ScanProsite analysis indicated that it is a putative solute carrier protein that contains a substrate binding site. CcSLC was detected in carp embryos by in situ hybridization in the 70%-epiboly, 6-somite, and 14-somite embryonic stages. Gene expression stopped at the long pec stage. However, CcSLC25a5 was re-expressed during the initiation of scale formation in the regions that were scale covered. These findings provide novel insights into the features of early carp embryo and scale development.
KeywordsCyprinus carpio Linnaeus Scale development Solute carrier protein Scale initiation Embryo development
Membrane transporters are the gatekeepers for all cells and organelles, controlling uptake and efflux of crucial compounds such as sugars, nucleotides, inorganic ions, and drugs (Hediger et al. 2004). They are responsible for substrate movement across both cytoplasmic membranes of cells and internal membranes of organelles (Sreedharan et al. 2011). Transporters can be divided into ABC transporters, pumps, ion channels, water channels, and solute carriers. Membrane bound proteins represent about 27% of the entire human proteome. Among the membrane bound proteins, the SLC transporters are the second largest group after G protein coupled receptors (Lagerstrom 2008Almen et al. 2009). Transporters can be divided into two families, passive and active transporters. The active transporters use diverse energy-coupling mechanisms to allow the movement of molecules across a membrane against a concentration gradient. The passive transporters, also known as facilitated transporters, allow passage of solutes (e.g., glucose, amino acids, urea) across membranes down their electrochemical gradients (Hediger et al. 2004).
Appreciation of the role that transport proteins play in the absorption, distribution, and elimination of a wide variety of drugs in clinical use is increasing. As the largest group of secondary transporters, SLC transporters are becoming the focus of an increasing number of studies because they control transmembrane movement of many types of important substrates. The human genome contains approximately 360 unique SLC protein genes grouped into 48 families (Ren et al. 2007; Fredriksson et al. 2008). Approximately 19 of the SLC gene families have been reported to transport xenobiotics including: organic anion polypeptides (SLCO), oligopeptides (SLC15) (Russel et al. 2002; Brandsch et al. 2008; Dobson and Kell 2008; Rubio and Daniel 2008), organic anion/cations (SLC22) (Koepsell et al. 2007; Ciariboli 2008), and organic cations (SLC47) (Tanihara et al. 2007; Moriyama et al. 2008; Matsushima et al. 2009).
The SLC25 gene encodes mitochondrial carriers (MCs), which are membrane-integrated proteins that localize to the inner membranes of mitochondria and catalyze the translocation of solutes across the membranes (Plamieri, 2004). The MCs provide a critical link between the mitochondria and the cytosol by facilitating the flux of solutes through the permeable barrier of the inner mitochondrial membrane. The substrates transported by the MCs range from the smallest H+ to the largest ATP molecule, implying that they have a broad array of functions in diverse metabolic processes. Defects in MC genes lead to several diseases such as type II citrullinaemia (SLC25A13; OMIM 215700), hyperornithine-hyperammone-homocitrulline-mia (HHH) syndrome (SLC25A15; OMIM 238970), Stanley syndrome (SLC25A20; OMIM 212138), Amish microcephaly (SLC25A20; OMIM 607196), and autosomal dominant progressive external ophthalmoplegia (adPEO) (SLC25A4; OMIM 157640). The complete amino acid sequence of the ATP/ADP carrier was identified in beef heart mitochondria (Aquila et al. 1982; Aquila et al. 1985).
Post-genomic era studies have enabled us to identify many more mitochondria carrier families (MCFs) simultaneously without laborious cloning or purification procedures. Although much is known about the characteristics and functions of MCFs in human and plants, their biological roles in fish remain unknown. In our studies, we cloned the CcSLC25a5 (Cyprinus Carpio SLC25a5) gene using Genefishing kits from the skins of the mirror carp, which has interspersed scales, and the Jianli, that has full scales. The expression pattern of SLC25a5 during different developmental stages was determined by whole-mount in situ hybridization.
Materials and methods
Mirror carp and Jianli (Cyprinus carpio Linnaeus) were cultivated at Experimental Station of the Wuxi Freshwater Center, Jiangsu, China. The mirror carp was derived by domesticating the common carp and selecting for a scale-reduced mutation fgfr1a (Rohner et al. 2009). The skin tissues from mirror carp and Jianli were harvested with forceps and immediately homogenized in 1 ml Trizol (Invitrogen).
First-strand cDNA synthesis
Total RNA extracted from the skin tissues using Trizol reagent (Invitrogen) was used to synthesis the first-strand cDNA. Subsequent reverse transcription was performed according to the manufacture’s protocol (Seegene, Seoul, South Korea). The final reaction volume was 20 uL and contained: 3 ug of purified total RNA, 4 uL of 5× reaction buffer, 5 uL of dNTPs (2 mM each), 2 uL of 10 uM dT-ACP1 (5′-GTCTACCAGGCATTCGCTTCATXXXXXGCCATCGACC-3′), 0.5 uL RNase inhibitor (40 U/uL; Invitrogen, USA), and 1 uL of reverse transcriptase (200 U/uL, Invitrogen). First-strand cDNAs were diluted using 80 uL of DNase-free water for GenefishingTM PCR, and stored at -20°C.
ACP (Annealing Control Primer)-based Genefishing PCR
DEGs (Differential Expressed Genes) were screened by ACP-based PCR methodology using the Genefishing DEG Kits (Seegene). Briefly, second-strand cDNA was synthesized at 50°C during in the first-stage PCR reaction. The final reaction was conducted in a 20 uL volume containing: 3–5 uL of diluted first-strand cDNA, 1 uL of dT-ACP2 (10 uM), 1 uL of 10 uM arbitrary ACP (Hwang et al. 2005), and 10 uL of 2× Master Mix (Seegene). The PCR protocol for second-strand synthesis was: one cycle at 94°C for 5 minutes, followed by 50°C for 3 minutes, and 72°C for 1 minute. Once the second-strand DNA synthesis was completed, a second-stage PCR amplification protocol was conducted that consisted of: 40 cycles of 94°C for 40 seconds, 65°C for 40 seconds, and a 5 minute final extension at 72°C. The amplified PCR products were separated in a 2% agarose gel and stained with ethidium bromide.
Cloning and sequencing
PCR bands indicating genes with differential expression were extracted from the gel using a DNA extraction kit (Zomanbio, China). The bands were directly cloned into a pEASY-T vector (Trans, China) according to the manufacturer’s instructions. The cloned plasmids were sequenced.
Whole-mount in situ hybridization
RNA probes were prepared from a 206 bp CDS (Coding Sequence) region of the gene SLC25a5 in common carp and labeled with digoxigenin-UTP using T3 or T7 RNA polymerase (T3 for production of the antisense probe, T7 for the sense probe). The embryonic and developmental stages of the embryos used for whole-mount in situ hybridization were assessed using haf (hours after fertilization) and various morphological criteria (Kane and Kimmel 1993) as described by Westerfield (1993). The RNA probes were hybridized to the tissue overnight at 65°C. The embryos and juvenile fish from each developmental stage were imaged using an Olympus BH-2 microscope (Olympus Optical, Tokyo, Japan). The primers used to create the probes were: Forward: 5′-TGGGTAACTGCTTGGTGAAGATCTCC-3′, and Reverse: 5′-ACCAGCAACAGCAGTCACAGTCTGA-3′.
The mirror carp and Jianli have differential gene expression in skin tissues
Primers used in genefishing for amplifying the differential expressed genes in skin of jianli and mirror carp
Seven candidate GOIS (gene of interest) by genefishing
Solute carrier family 25 alpha, member 5 (slc25a5)
Cyprinus carpio translationally-controlled tumor protein mRNA, complete cds
Danio rerio myosin heavy chain, fast skeletal muscle-like, 85 bp (89%)
Actin, alpha, cardiac muscle 1 b [Danio rerio], 367/389 (94%)
Dictyostelium discoideum AX4 hypothetical protein, 84/87 (97%)
Fibroblast growth factor 4
CcSLC25a5 gene structure and its isoforms
Phylogenetic analysis of cyprinid fishes and mammalian SLC25a5 isoforms
Tissue expression of the CcSLC25a5
Scales of the teleost fish are important skin integumentary appendages distributed over the body surface in defined patterns. Natural variation in scale patterns exists among the common carp species. Mirror carp and Jianli are two carp varieties that have distinct scale patterns as a result of breeding selection. Scale initiation and morphogenesis are very complicated biological processes. The functional analysis of FGFR1 by reverse genetics showed that the mutation of this gene can lead to reduced scales and abnormal fins (Rohner et al. 2009). The scale is one of the important agricultural traits for fishes and play important roles in physiology, defense, and adaptation to new environments (Sire et al. 1997). Some aquatic biologists are interested in scale development and launched some works using the reverse genetics. However, a complete knowledge of scale development is limited due to the longer sexual maturation period and the larger genome size for many species in fishes. Therefore, the molecular mechanisms underlying the scale initiation and pattern formation remain unknown. Using Genefishing, we were able to identify seven genes that were differentially expressed in Jianli and mirror carp skin tissues (Table 2). These genes may contribute to the morphogenesis of the integumentary appendages, especially the scales or fins, the functional analysis of these seven genes will be performed in future studies.
ANTs are the most abundant mitochondrial proteins and mediate the exchange of ADP and ATP across the mitochondrial membrane. They link ATP production in mitochondria to its functional utilization for energy requirements outside mitochondria (Klingenberg 1981 and 1989). Humans are known to have three ANT genes. ANT1 is predominantly expressed in the heart and skeletal muscle and ANT2 is expressed in kidney and liver. ANT3 is expressed ubiquitously but is highest in the kidney (Stepien et al. 1992). The tissue distributions of different ANT isoforms seem to reflect their functional differences and associate with tissue-specific energy metabolism (Stepien et al. 1992).
Given their tissue specific roles in humans, it was of interest to examine expression profiles of ANT isoforms in various tissues in the carp. To date, there are no reports about ANT expression in fish scales. Herein, we report that ANT2 is specifically expressed in the scale placods. This result indicates that ANT2 may have an important role in scale development and morphogenesis. It has been suggested that fish ANTs have an important role in energy production, which is associated with temperature adaptation in fish. Guderley and Johnston (1996) reported that the uptake of ADP in isolated mitochondria from cold-acclimated sculpin was higher than that of their warm-acclimated counterparts. CcSLC25a5 possibly involved in the energy production in scale development for fishes, so it should be expressed in the process of scale development. Additional studies will provide new insights into the regulation of energy metabolism during scale development in fish.
We next examined the expression profiles of CcSLC25a5 in various tissues of the Jianli during development. CcSLC25a5 was weakly expressed in early stages of embryo development (4.5 to 6 hpf, Figure 5A-B). However, strong expression signals were detected in embryos from 10 to 24 hpf (Figure 5C-F). These results imply that CcSLC25a5 has roles in embryo and scale development.
This study was supported by the grants from the Research Foundation of the Chinese Academy of Fishery Sciences (No. 2011C015, No. 2010C017, No 2012C015), the China Ministry of Agriculture 948 Program (2011-G12), and the China Ministry of Science and Technology 863 Hi-Tech Research and Development Program (No.2011AA100401).
- Almen MS, Nordstrom KJ, Fredriksson R, Schioth HB: Mapping the human membrane proteome: a majority of the human membrane proteins can be classified according to function and evolutionary origin. BioMed Central Biology. 2009, 7: 50. doi:10.1186/1741-7007-7-50Google Scholar
- Aquila H, Misra D, Eulitz M, Klingenberg M: Complete amino acid sequence of the ADP/ATP carrier from beef heart mitochondria. Hoppe-Seyler’s Z Physiol Chem 1982, 363: 345-349.View ArticleGoogle Scholar
- Aquila H, Link TA, Klingenberg M: The uncoupling protein from brown fat mitochondria is related to the mitochondrial ADP/ATP carrier. Analysis of sequence homologies and of folding of the protein in the membrane. EMBO J 1985, 4: 2369-2376.Google Scholar
- Bof M, Brandolin G, Satre M, Klein G: The mitochondrial adenine nucleotide translocator from Dictyostelium discoideum. Functional characterization and DNA sequencing. European Journal of Biochemistry 1999, 259: 795-800.View ArticleGoogle Scholar
- Brandsch M, Knutter I, Bosse-Doenecke E: Pharmaceutical and pharmacological importance of peptide transporters. J Pharm Pharmacol 2008, 60: 543-585. 10.1211/jpp.60.5.0002View ArticleGoogle Scholar
- Ciariboli G: Organic cation transporters. Xenobiotica 2008, 38: 936-971. 10.1080/00498250701882482View ArticleGoogle Scholar
- Dobson PD, Kell DB: Carrier-mediated cellular uptake of pharmaceutical drugs: an exception or the rule? Nat Rev Drug Discov 2008, 7: 205-220. 10.1038/nrd2438View ArticleGoogle Scholar
- Finn RD, Mistry J, Coggill P, Heger A, Pollington JE, Gavin OL, Gunasekaran P, Ceric G, Forslund K, Holm L, Sonnhammer EL, Eddy SR, Bateman A: The Pfam protein families database. Nucleic Acids Res 2010, 38: 211-222. 10.1093/nar/gkp985View ArticleGoogle Scholar
- Fredriksson R, Nordström KJV, Stephansson O, Hägglund MGA, Schiöth HB: The solute carrier (SLC) complement of the human genome: Phylogenetic classification reveals four major families. FEBS Lett 2008, 582: 3811-3816. 10.1016/j.febslet.2008.10.016View ArticleGoogle Scholar
- Guderley H, Johnston LA: Plasticity of fish muscle mitochondria with thermal acclimation. J Exp Biol 1996, 199: 1311-1317.Google Scholar
- Hediger MA, Michael F, Romero MF, Peng JB, Rolfs A, Takanaka H, Bruford EA: The ABCs of solute carriers: physiological, pathological and therapeutic implications of human membrane transport proteins. Pflügers Archive European Journal of Physiology 2004, 447: 465-468. 10.1007/s00424-003-1192-yView ArticleGoogle Scholar
- Hwang DY, Cho JS, Oh JH, Shim SB, Jee SW, Lee SH, Seo SJ, Lee SK, Lee SH, Kim YK: Differentially Expressed Genes in Transgenic Mice Carrying Human Mutant Presenilin-2 (N141I): Correlation of Selenoprotein M with Alzheimer’s Disease. Neurochem Res 2005, 30: 1009-1019. 10.1007/s11064-005-6787-6View ArticleGoogle Scholar
- Itoi S, Misaki R, Hirayama M, Nakaniwa M, Liang CS, Kondo H, Watabe S: Identification of three isofoms for mitochondrial adenine nucleotide translocator in the pufferfish Takifugu rubripes. Mitochondrion 2005, 5: 162-172. 10.1016/j.mito.2005.01.003View ArticleGoogle Scholar
- Kane DA, Kimmel CB: The zebrafish midblastula transition. Development 1993, 119: 447-456.Google Scholar
- Kimura M: A simple method for estimating evolutionary rates of base substitutions through comparative studies of nucleotide sequences. J Mol Evol 1980, 16: 111-120. 10.1007/BF01731581View ArticleGoogle Scholar
- Klingenberg M: Membrane protein oligomeric structure and transport function. Nature 1981, 290: 449-454. 10.1038/290449a0View ArticleGoogle Scholar
- Klingenberg M: Molecular aspects of the adenine nucleotide carrier from mitochondria. Arch Biochem Biophys 1989, 270: 1-14. 10.1016/0003-9861(89)90001-5View ArticleGoogle Scholar
- Koepsell H, Lips K, Volk C: Polyspecific organic cation transporters: structure, function, physiological roles, and biopharmaceutical implications. Pharm Res 2007, 24: 1227-1251. 10.1007/s11095-007-9254-zView ArticleGoogle Scholar
- Lagerstrom MC, Schioth HB: Structural diversity of G protein-coupled receptors and significance for drug discovery. Nat Rev Drug Discov 2008, 7: 339-357. 10.1038/nrd2518View ArticleGoogle Scholar
- Matsushima S, Maeda K, Inoue K, Ohta KY, Yuasa H, Kondo T, Nakayama H, Horita S, Kusuhara H, Sugiyama Y: The inhibition of human multidrug and toxin extrusion 1 is involved in the drug-drug interaction caused by cimetidine. Drug Metabolism Disposition 2009, 37: 555-559. 10.1124/dmd.108.023911View ArticleGoogle Scholar
- Moriyama Y, Hiasa M, Matsumoto T, Omote H: Multidrug and toxic compound extrusion (MATE)-type proteins as anchor transporters for the excretion of metabolic waste products and xenobiotics. Xenobiotica 2008, 38: 1107-1118. 10.1080/00498250701883753View ArticleGoogle Scholar
- Plamieri F: The mitochondrial transporter family (SLC25): physiological and pathological implications. Pflügers Archive European Journal of Physiology 2004, 447: 689-709. 10.1007/s00424-003-1099-7View ArticleGoogle Scholar
- Ren Q, Chen K, Paulsen IT: Transporter DB: A comprehensive database resource for cytoplasmic membrane transport systems and outer membrane channels. Nucleic Acids Res 2007, 35: 274-279. 10.1093/nar/gkl925View ArticleGoogle Scholar
- Rohner N, Bercsényi M, Orbán L, Kolancayk ME, Linke D, Brand M, Nüsslein-Volhard C, Harris MP: Duplication of fgfr1 Permits Fgf Signaling to Serve as a Target for Selection during Domestication. Curr Biol 2009, 19: 1642-1647. 10.1016/j.cub.2009.07.065View ArticleGoogle Scholar
- Rubio AI, Daniel H: Peptide transporters and their roles in physiological processes and drug disposition. Xenobiotica 2008, 38: 1022-1042. 10.1080/00498250701875254View ArticleGoogle Scholar
- Russel FG, Masereeuw R, Van ARA: Molecular aspects of renal anionic drug transport. Annu Rev Physiol 2002, 64: 563-594. 10.1146/annurev.physiol.64.081501.155913View ArticleGoogle Scholar
- Sire JY, Allizard F, Babiar O, Bourguignon J, Quilhac A: Scale development in zebrafish (Danio rerio). J Anat 1997, 190: 545-561. 10.1046/j.1469-7580.1997.19040545.xView ArticleGoogle Scholar
- Sreedharan S, Stephansson O, Schiöth HB, Fredriksson R: Long evolutionary conservation and considerable tissue specificity of several atypical solute transporters. Gene 2011, 478: 11-18. 10.1016/j.gene.2010.10.011View ArticleGoogle Scholar
- Stepien G, Torroni A, Chung AB, Hodge JA, Wallace DC: Differential expression of adenine nucleotide translocator isoforms in mammalian tissues and during muscle cell differentiation. J Biol Chem 1992, 267: 14592-14597.Google Scholar
- Tanihara Y, Masuda S, Sato T, Katsura T, Ogawa O, Inui K: Substrate specificity of MATE1 and MATE2-K human multidrug and toxin extrusions/H(+)-organic cation antiporters. Biochemistry Pharmacology 2007, 74: 359-371. 10.1016/j.bcp.2007.04.010View ArticleGoogle Scholar
- Westerfield M: The zebrafish book: a guide for the laboratory use of zebrafish (Brachydanio rerio). M. Westerfield, Eugene, OR; 1993.Google Scholar
This article is published under license to BioMed Central Ltd. This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.